We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01131520
First Posted: May 27, 2010
Last Update Posted: August 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Friends Research Institute, Inc.
May 21, 2010
May 27, 2010
December 20, 2016
August 21, 2017
August 21, 2017
June 2010
December 2012   (Final data collection date for primary outcome measure)
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ]
    The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.
  • Hair Testing [ Time Frame: 3 month post-baseline ]
    The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and THC [ Time Frame: 3 month post-baseline ]
Complete list of historical versions of study NCT01131520 on ClinicalTrials.gov Archive Site
  • Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale [ Time Frame: 3 months post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ]
    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ]
    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.
  • Hair Testing [ Time Frame: 6 month post-baseline ]
    The predicted probabilities for testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC), calculated from generalized estimating equations.
  • Hair Testing [ Time Frame: 12 month post-baseline ]
    Predicted Probabilities for testing positive on the Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and THC, calculated from generalized estimating equations.
  • Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale [ Time Frame: 6 month post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
  • Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score [ Time Frame: 12 month post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 3 months post-baseline ]
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ]
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and THC [ Time Frame: 6 month post-baseline ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and THC [ Time Frame: 12 month post-baseline ]
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 6 month post-baseline ]
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 12 month post-baseline ]
Not Provided
Not Provided
 
Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
SBIRT in New Mexico
The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.
Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Drug Abuse
  • HIV Risk Behavior
  • Behavioral: Computerized brief intervention
    This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.
  • Behavioral: Counselor delivered brief intervention
    This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.
  • Experimental: Computerized Brief Intervention
    Computerized one-session brief intervention for drug use
    Intervention: Behavioral: Computerized brief intervention
  • Active Comparator: Counselor delivered brief intervention
    This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing
    Intervention: Behavioral: Counselor delivered brief intervention

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
360
July 2015
December 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years or older
  • Moderate risk category on the ASSIST scores

Exclusion Criteria:

  • planning to move out of New Mexico in the next year
  • receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01131520
08-08-173
R01DA026003 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
Friends Research Institute, Inc.
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert P Schwartz, M.D. Friends Research Institute, Inc.
Friends Research Institute, Inc.
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP